市场调查报告书
商品编码
1290785
结扎设备市场 - 按产品(器械、配件),按手术类型(MIS、开放手术),按应用(胃肠道和腹部手术),按最终用途及预测,2023 - 2032年Ligation Devices Market - By Product (Instruments, Accessories), By Procedure Type (MIS, Open Surgery), By Application (Gastrointestinal & Abdominal Surgery), By End-use & Forecast, 2023 - 2032 |
全球结扎设备市场规模将在2032年之前呈指数式增长。政府对医疗基础设施的投资不断增加,是市场增长背后的一个主要驱动力。2022年10月,美国政府宣布投资约1.1亿美元以改善农村人口的医疗保健。此外,这一领域的行业参与者正专注于合併和收购战略,以加强他们的地位。举个例子,2022年8月,领先的医疗技术制造商CONMED公司收购了医疗设备创业公司Biorez, Inc.
整个结扎器械市场根据产品、程序、应用、终端用途和地区进行细分。
从2023年到2032年,结扎器械市场份额将以有利可图的复合年增长率增长。心血管疾病病例的激增增加了手术的数量,推动了对结扎器械的需求。根据CDC的数据,仅在美国就有约6000万妇女被诊断患有某种形式的心脏疾病。此外,业内人士为推出具有先进功能的结扎器械所做的努力将进一步促进该领域的增长。
在应用方面,泌尿外科领域的结扎器械市场价值将在2032年之前获得巨大收益。膀胱癌、前列腺癌等泌尿系统疾病的发病率上升,增加了对泌尿系统手术的需求,提升了对结扎设备的需求。举例来说,根据美国癌症协会的数据,2023年,仅在美国估计就有约82,290个膀胱癌新病例被诊断出来。
就终端用途而言,非住院手术中心部分的结扎设备市场规模将在2032年之前明显扩大。这些设施中先进的结扎设备的可用性增加了病人的偏好。此外,对门诊手术的需求激增,进一步增加了对非住院手术中心(ASCs)的需求。全球ASC数量的增加导致结扎设备的需求激增,从而导致市场扩张。
从区域角度看,欧洲结扎设备市场份额将在2023年至2032年期间以显著的复合年增长率增长。对微创手术的需求不断增加,加上癌症、心脏病等慢性病的发病率上升,增加了该地区对结扎设备的需求。此外,蓬勃发展的医疗保健部门将进一步为区域增长铺平道路。区域内企业对产品创新的大量投资也将对行业格局产生积极影响。
Global Ligation Devices Market size will expand exponentially through 2032. Increasing investments by the government in healthcare infrastructure is a major driver behind the market growth. In October 2022, the U.S. government announced an investment of around USD 110 million to improve healthcare for the rural population. Moreover, industry players in this space are focusing on mergers and acquisition strategies to reinforce their position. Citing an instance, in August 2022, CONMED Corporation, a leading medical technology manufacturer, acquired Biorez, Inc., a medical device start-up.
The overall ligation devices market is segmented based on product, procedure, application, end-use, and region.
The ligation instruments market share will grow at a lucrative CAGR from 2023 to 2032. Surging cases of cardiovascular disorders have increased the number of surgeries, propelling the need for ligation instruments. According to CDC, around 60 million women are diagnosed with some form of heart disease in the U.S. alone. Moreover, surging efforts by industry players toward launching ligation instruments with advanced capabilities will further contribute to segment growth.
Regarding application, ligation devices market value from the urological surgery segment will amass significant gains through 2032. Rising prevalence of urological conditions such as bladder cancer, prostate cancer, and others has increased the need for urological surgeries, elevating the demand for ligation devices. To illustrate, as per the American Cancer Society, in 2023, around 82,290 new cases of bladder cancer are estimated to be diagnosed in the U.S. alone.
With respect to end-use, the ligation devices market size from the ambulatory surgical centers segment will expand notably through 2032. The availability of advanced ligation equipment in these facilities has increased patient preference. Moreover, the surging demand for outpatient surgeries has further increased the demand for ambulatory surgical centers (ASCs). The increasing number of ASCs worldwide has led to a surge in the demand for ligation devices, resulting in market expansion.
From the regional standpoint, Europe ligation devices market share will grow at a notable CAGR from 2023 to 2032. Increasing demand for minimally invasive procedures coupled with the rising prevalence of chronic diseases such as cancer, heart disease, and others have increased the demand for ligation devices in the region. Moreover, the flourishing healthcare sector will further pave the way for regional growth. Significant investments by regional players in product innovations will also positively affect the industry landscape.